JLS Fund

JLS Fund is a venture capital firm based in New York, focusing on early-stage investments in technology companies across various sectors. The firm primarily invests in the United States, targeting innovative startups in fields such as neuroscience, mental health, biotechnology, pharmaceuticals, healthcare, and psychedelic medicine. JLS Fund's investment strategy encompasses a range of stages, including Pre-Seed, Seed, Series A, Growth, Late Stage, Pre-IPO, and Buyout, allowing for flexibility in supporting companies at different phases of development. The firm's portfolio includes companies like Enthea, Gilgamesh, Cybin, MindMed, Awkn Life Sciences Inc, and Psilera Bioscience, reflecting its commitment to advancing groundbreaking solutions in the healthcare and technology sectors. JLS Fund's approach combines financial support with strategic guidance, aiming to foster the growth of companies that are poised to make significant impacts in their respective industries. By leveraging its expertise and network, the firm seeks to identify and nurture ventures that align with its vision of driving innovation and improving lives through technological advancements.